首页|Nrf2调控的氧化应激在Adropin抑制低氧肺动脉平滑肌细胞增殖中的作用研究

Nrf2调控的氧化应激在Adropin抑制低氧肺动脉平滑肌细胞增殖中的作用研究

扫码查看
目的 观察Adropin对低氧诱导的SD大鼠肺动脉平滑肌细胞(PASMCs)增殖及氧化应激的影响,并探讨其可能机制.方法 以1%的O2作为诱导剂,建立PASMCs增殖及氧化应激的细胞模型,通过活性氧(ROS)激活剂H2O2,抗氧化剂N-乙酰半胱氨酸(NAC)及不同浓度Adropin(100、300、1000 nmol·L-1)干预24 h后,检测细胞增殖及ROS,筛选Adropin抑制增殖及氧化应激的最适浓度.选择1000 nmol·L-1 Adropin和/或核因子E2相关因子2(Nfr2)抑制剂ML385在低氧条件下孵育PASMCs 24 h,并设置Nrf2激活剂富马酸二甲酯(DMF)作为阳性对照组,通过CCK-8试剂盒检测细胞增殖;DCFH-DA探针联合荧光酶标仪测定细胞内ROS的水平;试剂盒检测细胞内超氧化物歧化酶(SOD)、谷胱甘肽过氧化物酶(GPx)、过氧化氢酶(CAT)、丙二醛(MDA)的水平;流式细胞仪检测细胞周期;Western blot检测Nrf2、细胞周期蛋白(Cyclin)D1、Cyclin E的表达.结果 与对照组相比较,H2O2及低氧均能够诱导PASMCs增殖及ROS生成,而不同浓度的Adropin(100、300、1000 nmol·L-1)和NAC均可抑制低氧诱导的PASMCs增殖及ROS产生,且Adropin抑制增殖及ROS产生具有浓度依赖性.与低氧组相比较,DMF或Adropin(1000 nmol·L-1)干预后,PASMCs增殖及细胞内ROS水平下降,SOD、GPx、CAT活性增加,MDA水平下降,Nrf2表达上调(P<0.05),而ML385能够逆转Adropin的上述作用(P<0.05);DMF或Adropin能够通过抑制Cyclin D1与Cyclin E的表达,阻滞细胞周期于G0/G1期,从而抑制PASMCs增殖(P<0.05),而ML385能够逆转Adropin上述作用(P<0.05).结论 Adropin可通过抑制氧化应激抑制低氧诱导的PASMCs增殖,其机制可能与激活Nrf2有关.
Role of Nrf2 regulated oxidative stress in inhibition of hypoxia-induced pulmonary artery smooth muscle cell proliferation by Adropin
Objective To determine the effect of Adropin on hypoxia-induced proliferation and oxidative stress in pulmonary artery smooth muscle cells(PASMCs)of SD rats,and its possible mechanisms.Methods The 1%O2 was used to induce the proliferation and oxidative stress of PASMCs,and then the reactive oxygen species(ROS)activator H2O2,antioxidant N-acetylcysteine(NAC)and different concentrations of Adropin(100,300,and 1000 nmol·L-1)were used for PASMCs for 24 h.The cell proliferation and levels of ROS were measured to determine the optimal concentration of Adropin for inhibiting the proliferation and oxidative stress.To explore the molecular mechanisms of how Adropin suppressed the proliferation and oxidative stress of PASMCs,1000 nmol·L-1Adropin and/or Nuclear factor erythroid 2-related factor 2(Nfr2)inhibitor ML385 were used to treat PASMCs for 24 h under hypoxic conditions.Nfr2 activator dimethyl fumarate(DMF)was used for the positive control group.The cell proliferation was analyzed by the CCK-8 kit;the intracellular ROS level was measured by DCFH-DA with fluorescence microplate reader.Intracellular superoxide dismutase(SOD),glutathione peroxidase(GPx),catalase(CAT),and malondialdehyde(MDA)were determined with the kits.Cell cycle was detected by flow cytometry;the expressions of Nrf2,Cyclin D1 and Cyclin E were measured by Western blot.Results H2O2 and hypoxia-induced the proliferation and ROS production in PASMCs,while different concentrations of Adropin(100,300,and 1000 nmol·L-1)decreased the proliferation and ROS production in hypoxia-exposed PASMCs in a concentration-dependent manner.In addition,the effects of antioxidant NAC on the inhibition of proliferation and ROS production were comparable with those of 1000 nmol·L-1 Adropin.Specifically,Adropin and DMF pretreatment downregulated the level of ROS and MDA,and upregulated the expression of antioxidant-related factors(SOD,GPx and CAT)via Nrf2 activation(P<0.05).Adropin and DMF blocked the proliferation of hypoxia-exposed PASMCs by arresting the cell cycle progression in G0/G](P<0.05).In accordance with these findings,DMF and Adropin induced inhibition of the cell cycle was associated with the inhibition of Cyclin D1 and Cyclin E(P<0.05).Moreover,ML385 reversed the beneficial effects of Adropin on hypoxia-stimulated PASMCs(P<0.05).Conclusion Adropin suppresses the proliferation of hypoxia-induced PASMCs via inhibition of the oxidative stress,whose mechanism may be related to the activation of Nrf2.

Adropinhypoxiapulmonary artery smooth muscle cellproliferationoxidative stressnuclear factor erythroid 2-related factor 2

陈昌贵、易春峰、王栋、余志华、贺立群

展开 >

武汉市第一医院心血管内科,武汉 430022

Adropin 低氧 肺动脉平滑肌细胞 增殖 氧化应激 核因子E2相关因子2

湖北省自然科学基金资助项目

2019CFB405

2024

中南药学
湖南省药学会

中南药学

CSTPCD
影响因子:0.736
ISSN:1672-2981
年,卷(期):2024.22(1)
  • 3